Skip to main content
. 2018 Dec 18;9(99):37319–37332. doi: 10.18632/oncotarget.26470

Figure 1. Tissue microarray based immunohistochemistry analysis of PARP and XIAP in breast cancer (BC) patients.

Figure 1

BC TMA spots showing overexpression of PARP (A) and XIAP (B). In contrast, another set of TMA spots showing reduced expression of PARP (C) and XIAP (D). 20 X/0.70 objective on an Olympus BX 51 microscope. (Olympus America Inc, Center Valley, PA, USA) with the inset showing a 40× 0.85 aperture magnified view of the same TMA spot.